Two mycobacteriophages were administered intravenously to a male with treatment-
refractory Mycobacterium abscessus pulmonary infection and severe cystic fibrosis lung …

The opportunistic pathogen Mycobacterium abscessus (Mab) causes fatal lung infections
that bear similarities—and notable differences—with tuberculosis (TB) pulmonary disease …

Tuberculosis (TB) remains a threat to human health worldwide. Mycobacterium tuberculosis
(Mtb) and other nontuberculous mycobacteria (NTM) can form biofilms, and in vitro and …

Pulmonary drug delivery system is increasingly gaining popularity for several lung diseases
including tuberculosis (TB) due to its ability to attain high drug concentrations at the site of …

Infections caused by nontuberculous mycobacteria have increased more than 50% in the
past two decades and more than doubled in the elderly population. Mycobacterium …

Background Africa is challenged by the emergence of antimicrobial resistance (AMR). In
order to improve patient management and to optimise approaches to curb the spread of …

Global infections by nontuberculous mycobacteria (NTM) are steadily rising. New drugs are
needed to treat NTM infections, but the NTM drug pipeline remains poorly populated and …

Mycobacterium abscessus is a non-tuberculous mycobacterium notoriously known for
causing severe, chronic infections. Treatment of these infections is challenging due to either …

Nontuberculous mycobacterial pulmonary disease (NTM-PD) is a potentially fatal infectious
disease requiring long treatment duration with multiple antibiotics and against which there is …

Background The prevalence of nontuberculous mycobacteria (NTM) infections is rising in
people with cystic fibrosis (pwCF). NTM infection, especially infection with Mycobacterium …